Simplify ADC Development with AJICAP™
AJICAP™ supports bioconjugate development from early evaluation through clinical manufacturing using an adaptable engagement model. The combination of early-stage evaluation, technology licensing, and flexible manufacturing options provides an efficient pathway from concept to clinical supply.
Remove Constraints at Every Step of the Process
AJICAP™ provides a flexible pathway from early evaluation to clinical manufacturing. Programs typically begin with feasibility studies and sample preparation. For qualifying programs, AJICAP™ technology can be accessed through a licensing model that supports broader development activities. AJICAP™ provides process development, analytical support, and technology transfer, while GMP manufacturing is performed by qualified partners.
Inquiry & Evaluation
Initial technical discussion
Feasibility assessment
Sample preparation
AJICAP™ conjugation and linker technology evaluation
Development & Optimization
Conjugation process development
Linker-payload optimization
Analytical characterization
Technology selection and development planning
Technology Transfer & Manufacturing Preparation
Process transfer package
Transfer to customer or customer-selected CDMO
Analytical method transfer
Manufacturing strategy development
Clinical Manufacturing & Supply
GMP manufacturing by qualified CDMO partners
Clinical supply support
Stability studies and release testing
Ongoing technical support
From Technology Access to Clinical Supply
Programs typically begin with feasibility studies and sample preparation. These activities help evaluate conjugation strategies, linker-payload options, and product characteristics before broader development decisions are made. For qualifying programs, AJICAP™ technology can be licensed for continued development and manufacturing. AJICAP™ provides process development, analytical characterization, and technology transfer support, helping customers establish robust and scalable conjugation processes. Manufacturing is performed by qualified partner CDMOs or customer-selected manufacturing partners. This flexible model allows customers to choose the manufacturing strategy that best fits their development needs while benefiting from AJICAP™ technology and technical expertise.
How AJICAP™ Works with Your CDMO
AJICAP™ provides conjugation and linker technologies, together with process development, analytical support, and technology transfer expertise. For programs requiring GMP manufacturing, customers may work with qualified AJICAP™ partner CDMOs or their preferred manufacturing partners. AJICAP™ supports technology transfer and process implementation to help establish robust and scalable manufacturing processes. AJICAP™ partner CDMOs offer prior experience with AJICAP™-enabled programs, helping to facilitate efficient development and clinical manufacturing.
Ready to move forward?
From first conjugate through Phase 1/2 cGMP clinical supply — one relationship, every stage.
Frequently Asked Questions
What does AJICAP™ provide?
AJICAP™ provides site-specific conjugation and linker technologies, together with process development, analytical support, and technology transfer expertise. Customers may work with AJICAP™ partner CDMOs or their preferred manufacturing partners for GMP production, depending on their development strategy.
How long is the engagement?
Engagement timelines vary depending on program scope and manufacturing requirements. For early-stage evaluation, AJICAP™ sample preparation can typically be completed within two weeks of receiving the necessary materials, enabling rapid assessment of conjugation feasibility. Development, technology transfer, and clinical manufacturing timelines are determined on a project-specific basis, taking into account program requirements, manufacturing strategy, and the selected CDMO partner.
Can I license the technology?
Yes. AJICAP™ is typically provided through a technology licensing model, enabling flexible use of AJICAP™ conjugation and linker technologies across customer programs. Prior to licensing, proof-of-concept studies and sample preparation can be supported depending on customer needs. Additional details are available on the Licensing & Transfer page.
Who manufactures the material?
AJICAP™ provides conjugation and linker technologies, together with process development, analytical support, and technology transfer. GMP manufacturing is performed by qualified third-party CDMO partners or customer-selected manufacturing partners, providing flexibility in manufacturing strategy and supply chain planning.
What if I need analytical support?
AJICAP™ provides analytical characterization and process development support for conjugate evaluation and development. Available services include DAR analysis, stability assessment, and related characterization studies. Analytical support is primarily provided for research and development activities and can support efficient development and technology transfer.